Small triple positive hepatitis B does not necessarily transform into liver cancer, and even for those who develop liver cancer, the length of time varies from person to person. Minor triple yang is a type of hepatitis B, which refers to positive surface antigen, e antibody and core antibody. If patients with normal liver function and abdominal ultrasound examination and low viral load, they are usually not easily transformed into liver cancer; patients with abnormal liver function or obvious cirrhosis have a higher possibility of transforming into liver cancer, but if they meet the indications for anti-hepatitis B virus treatment and undergo standardized antiviral treatment, those with better control will not develop cancer; if patients do not receive timely and systematic treatment, the possibility of developing into liver cancer is very If patients do not receive timely and systematic treatment, the possibility of developing into liver cancer is very high, and the time duration varies from person to person, ranging from several years to decades. In conclusion, patients with hepatitis B should have early standardized drug treatment, regular review, and get sufficient rest and good sleep.